JP5723104B2 - Emulsion composition for skin - Google Patents
Emulsion composition for skin Download PDFInfo
- Publication number
- JP5723104B2 JP5723104B2 JP2010069404A JP2010069404A JP5723104B2 JP 5723104 B2 JP5723104 B2 JP 5723104B2 JP 2010069404 A JP2010069404 A JP 2010069404A JP 2010069404 A JP2010069404 A JP 2010069404A JP 5723104 B2 JP5723104 B2 JP 5723104B2
- Authority
- JP
- Japan
- Prior art keywords
- mass
- component
- starch
- oil
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims description 35
- 239000000839 emulsion Substances 0.000 title claims description 14
- -1 alkenyl succinate Chemical compound 0.000 claims description 53
- 229920002472 Starch Polymers 0.000 claims description 23
- 239000008107 starch Substances 0.000 claims description 23
- 235000019698 starch Nutrition 0.000 claims description 23
- 239000003792 electrolyte Substances 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 16
- 229910052751 metal Inorganic materials 0.000 claims description 15
- 239000002184 metal Substances 0.000 claims description 15
- 229920000161 Locust bean gum Polymers 0.000 claims description 11
- 235000010420 locust bean gum Nutrition 0.000 claims description 11
- 239000000711 locust bean gum Substances 0.000 claims description 11
- 239000002736 nonionic surfactant Substances 0.000 claims description 6
- 229920000881 Modified starch Polymers 0.000 claims description 4
- 235000019426 modified starch Nutrition 0.000 claims description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 32
- 239000000194 fatty acid Substances 0.000 description 32
- 229930195729 fatty acid Natural products 0.000 description 32
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 23
- 230000000694 effects Effects 0.000 description 15
- 235000011187 glycerol Nutrition 0.000 description 14
- 238000003860 storage Methods 0.000 description 14
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 12
- 238000011156 evaluation Methods 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000000230 xanthan gum Substances 0.000 description 11
- 235000010493 xanthan gum Nutrition 0.000 description 11
- 229920001285 xanthan gum Polymers 0.000 description 11
- 229940082509 xanthan gum Drugs 0.000 description 11
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 239000002537 cosmetic Substances 0.000 description 10
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 10
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 8
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 150000004665 fatty acids Chemical class 0.000 description 6
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 6
- 229940075507 glyceryl monostearate Drugs 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- 229940058015 1,3-butylene glycol Drugs 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 235000010323 ascorbic acid Nutrition 0.000 description 5
- 239000011668 ascorbic acid Substances 0.000 description 5
- 235000019437 butane-1,3-diol Nutrition 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 229960000735 docosanol Drugs 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 5
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 4
- IZHVBANLECCAGF-UHFFFAOYSA-N 2-hydroxy-3-(octadecanoyloxy)propyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CCCCCCCCCCCCCCCCC IZHVBANLECCAGF-UHFFFAOYSA-N 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000002738 chelating agent Substances 0.000 description 4
- 238000004945 emulsification Methods 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 229920001296 polysiloxane Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 3
- NMUKKQFFBNEVJY-UHFFFAOYSA-K 4-O-bis[(4-oct-1-enoxy-4-oxobutanoyl)oxy]alumanyl 1-O-oct-1-enyl butanedioate Chemical compound [Al+3].CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O.CCCCCCC=COC(=O)CCC([O-])=O NMUKKQFFBNEVJY-UHFFFAOYSA-K 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 229940072107 ascorbate Drugs 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 229920001515 polyalkylene glycol Polymers 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 3
- 229940048086 sodium pyrophosphate Drugs 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 3
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 3
- FPJHWYCPAOPVIV-VOZMEZHOSA-N (2R,3S,4R,5R,6R)-6-[(2R,3R,4R,5R,6R)-5-acetamido-2-(hydroxymethyl)-6-methoxy-3-sulfooxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CO[C@@H]1O[C@H](CO)[C@H](OS(O)(=O)=O)[C@H](O[C@@H]2O[C@H]([C@@H](OC)[C@H](O)[C@H]2O)C(O)=O)[C@H]1NC(C)=O FPJHWYCPAOPVIV-VOZMEZHOSA-N 0.000 description 2
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical group OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 239000004147 Sorbitan trioleate Substances 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 229940051593 dermatan sulfate Drugs 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000010696 ester oil Substances 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 229940074045 glyceryl distearate Drugs 0.000 description 2
- 229940068939 glyceryl monolaurate Drugs 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- OVGXLJDWSLQDRT-UHFFFAOYSA-L magnesium lactate Chemical compound [Mg+2].CC(O)C([O-])=O.CC(O)C([O-])=O OVGXLJDWSLQDRT-UHFFFAOYSA-L 0.000 description 2
- 239000000626 magnesium lactate Substances 0.000 description 2
- 229960004658 magnesium lactate Drugs 0.000 description 2
- 235000015229 magnesium lactate Nutrition 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 2
- 235000010378 sodium ascorbate Nutrition 0.000 description 2
- 229960005055 sodium ascorbate Drugs 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 235000019337 sorbitan trioleate Nutrition 0.000 description 2
- 229960000391 sorbitan trioleate Drugs 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PAFJZWHXMSQJKV-UQZRNVAESA-N (3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol;octadecanoic acid Chemical compound OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.OC[C@@H](O)C1OC[C@H](O)[C@H]1O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O PAFJZWHXMSQJKV-UQZRNVAESA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- OKMWKBLSFKFYGZ-UHFFFAOYSA-N 1-behenoylglycerol Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(O)CO OKMWKBLSFKFYGZ-UHFFFAOYSA-N 0.000 description 1
- ZXNAIPHYBVMMPY-KTKRTIGZSA-N 1-erucoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(=O)OCC(O)CO ZXNAIPHYBVMMPY-KTKRTIGZSA-N 0.000 description 1
- QHZLMUACJMDIAE-SFHVURJKSA-N 1-hexadecanoyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)CO QHZLMUACJMDIAE-SFHVURJKSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- XFBOJHLYDJZYSP-UHFFFAOYSA-N 2,8-dioxoadenine Chemical compound N1C(=O)N=C2NC(=O)NC2=C1N XFBOJHLYDJZYSP-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- BHIZVZJETFVJMJ-UHFFFAOYSA-N 2-hydroxypropyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCC(C)O BHIZVZJETFVJMJ-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- GECRRQVLQHRVNH-MRCUWXFGSA-N 2-octyldodecyl (z)-octadec-9-enoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC GECRRQVLQHRVNH-MRCUWXFGSA-N 0.000 description 1
- QNJOVLAFLJQFBF-UHFFFAOYSA-N 2-octyldodecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C QNJOVLAFLJQFBF-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- GUOCOOQWZHQBJI-UHFFFAOYSA-N 4-oct-7-enoxy-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)OCCCCCCC=C GUOCOOQWZHQBJI-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 235000000378 Caryota urens Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 240000000163 Cycas revoluta Species 0.000 description 1
- 235000008601 Cycas revoluta Nutrition 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 235000000495 Erythronium japonicum Nutrition 0.000 description 1
- 240000000745 Erythronium japonicum Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 235000010103 Metroxylon rumphii Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- QHZLMUACJMDIAE-UHFFFAOYSA-N Palmitic acid monoglyceride Natural products CCCCCCCCCCCCCCCC(=O)OCC(O)CO QHZLMUACJMDIAE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000009936 Pteridium aquilinum Nutrition 0.000 description 1
- 240000005893 Pteridium aquilinum Species 0.000 description 1
- 235000010575 Pueraria lobata Nutrition 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 240000004922 Vigna radiata Species 0.000 description 1
- 235000010721 Vigna radiata var radiata Nutrition 0.000 description 1
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 1
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 description 1
- BKZCZANSHGDPSH-KTKRTIGZSA-N [3-(2,3-dihydroxypropoxy)-2-hydroxypropyl] (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)COCC(O)CO BKZCZANSHGDPSH-KTKRTIGZSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical group OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- SHZIWNPUGXLXDT-UHFFFAOYSA-N caproic acid ethyl ester Natural products CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- YSRSBDQINUMTIF-UHFFFAOYSA-N decane-1,2-diol Chemical compound CCCCCCCCC(O)CO YSRSBDQINUMTIF-UHFFFAOYSA-N 0.000 description 1
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- HRUVKSKSDDVGMC-JDYVBSGKSA-L disodium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;sulfate Chemical compound [Na+].[Na+].OS([O-])(=O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] HRUVKSKSDDVGMC-JDYVBSGKSA-L 0.000 description 1
- RLPQZSVUADVLBS-UHFFFAOYSA-L disodium;3-hydroxypropyl phosphate Chemical compound [Na+].[Na+].OCCCOP([O-])([O-])=O RLPQZSVUADVLBS-UHFFFAOYSA-L 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- DMMXZLMYEUEJFT-UHFFFAOYSA-N ethyl 16-methylheptadecanoate Chemical compound CCOC(=O)CCCCCCCCCCCCCCC(C)C DMMXZLMYEUEJFT-UHFFFAOYSA-N 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940087068 glyceryl caprylate Drugs 0.000 description 1
- 229940081618 glyceryl monobehenate Drugs 0.000 description 1
- 229940074774 glycyrrhizinate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008169 grapeseed oil Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 150000003893 lactate salts Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- NGPNWUWGVIIIDG-LEJBHHMKSA-L magnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP([O-])([O-])=O NGPNWUWGVIIIDG-LEJBHHMKSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical group 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010988 polyoxyethylene sorbitan tristearate Nutrition 0.000 description 1
- 239000001816 polyoxyethylene sorbitan tristearate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 229940026235 propylene glycol monolaurate Drugs 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 235000011078 sorbitan tristearate Nutrition 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000013826 starch sodium octenyl succinate Nutrition 0.000 description 1
- 239000001334 starch sodium octenyl succinate Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Description
本発明は、皮膚用乳化組成物に関する。 The present invention relates to an emulsified composition for skin.
乳化組成物に電解質を高配合すると、電解質の塩の影響により、乳化構造が崩壊して経時的な減粘が生じるといった問題があるため、電解質高配合乳化系を安定化させることは非常に困難である。 When an electrolyte is highly blended in an emulsified composition, there is a problem that the emulsified structure collapses and the viscosity decreases with time due to the influence of the electrolyte salt, so it is very difficult to stabilize the electrolyte highly blended emulsion system. It is.
従来より、電解質を配合した乳化系の安定性を向上させるために、種々の増粘剤を配合する試みがなされている。具体的には、アスコルビン酸の無機酸エステル、キサンタンガムおよびヒアルロン酸ナトリウムを含有する皮膚化粧料(例えば、特許文献1を参照)、ショ糖脂肪酸エステル、油剤、電解質、水およびアクリル酸系ポリマーを含有する水中油型乳化化粧料(例えば、特許文献2を参照)、アスコルビン酸、高級アルコール、ソルビタン脂肪酸エステル、ヤシ油脂肪酸ショ糖エステルおよび特定の増粘剤の一種または二種以上を含有する乳化型皮膚外用剤(例えば、特許文献3を参照)、特定のアスコルビン酸塩、特定の直鎖飽和高級アルコールおよびキサンタンガムを含有する水中油型乳化組成物(例えば、特許文献4を参照)などが提案されている。 Conventionally, attempts have been made to blend various thickeners in order to improve the stability of the emulsion system blended with the electrolyte. Specifically, skin cosmetics containing inorganic acid ester of ascorbic acid, xanthan gum and sodium hyaluronate (see, for example, Patent Document 1), sucrose fatty acid ester, oil agent, electrolyte, water and acrylic polymer An oil-in-water emulsified cosmetic (see, for example, Patent Document 2), an ascorbic acid, a higher alcohol, a sorbitan fatty acid ester, a coconut oil fatty acid sucrose ester, and one or more types of specific thickeners An external skin preparation (for example, see Patent Document 3), a specific ascorbate, an oil-in-water emulsion composition (for example, see Patent Document 4) containing a specific linear saturated higher alcohol and xanthan gum and the like have been proposed. ing.
しかしながら、これら試みに拠って、ある程度安定性を付与することはできるものの、電解質が高配合されている場合には、凝集を引き起こし易く、充分な増粘効果が得られ難いといった問題がある。また、電解質の塩の影響を低減するために、これら増粘剤を高配合とすると、塗布時の延展性に劣り、ムラ付きするために、べたつき感などの使用感に劣るといった問題がある。また、延展時にダマやカスが発生するといった問題もある。 However, though these attempts can provide stability to some extent, when the electrolyte is highly blended, there is a problem that aggregation is likely to occur and a sufficient thickening effect is difficult to obtain. Further, if these thickeners are blended in a high amount in order to reduce the influence of the electrolyte salt, there is a problem that the spreadability at the time of application is inferior and unevenness is inferior, resulting in inferior use feeling such as stickiness. There is also a problem that lumps and scum are generated during the extension.
そこで、電解質高配合乳化系の安定化に適していると言われる非イオン性多糖系増粘剤を用いた試みもなされている。具体的には、ビタミンC誘導体、ガム質およびセルロース系高分子を含有する化粧料(例えば、特許文献5を参照)、化粧品用活性剤、電解質およびセチルヒドロキシエチルセルロースを含有するゲル化局所用組成物(例えば、特許文献6を参照)、キサンタンガム又はカッパカラギーナン、ローカストビーンガム、ヒアルロン酸若しくはその塩又はヒドロキシエチルセルロース、多価金属塩を含有する皮膚外用剤(例えば、特許文献7を参照)、メチルセルロース、乳化剤、液状油剤および電解質を含有する水中油型気泡含有化粧料(例えば、特許文献8を参照)などが提案されている。 Therefore, an attempt has been made to use a nonionic polysaccharide thickener which is said to be suitable for stabilizing an electrolyte high-blending emulsion system. Specifically, a cosmetic preparation containing a vitamin C derivative, a gum and a cellulosic polymer (see, for example, Patent Document 5), a cosmetic active agent, an electrolyte, and a gelled topical composition containing cetyl hydroxyethyl cellulose (See, for example, Patent Document 6), xanthan gum or kappa carrageenan, locust bean gum, hyaluronic acid or a salt thereof, or hydroxyethyl cellulose, a polyvalent metal salt, a skin external preparation (see, for example, Patent Document 7), methyl cellulose, An oil-in-water type bubble-containing cosmetic containing an emulsifier, a liquid oil agent and an electrolyte (see, for example, Patent Document 8) has been proposed.
しかしながら、これら試みに拠って、ある程度安定性を高めることはできるものの、非イオン性多糖系増粘剤は、それ自体の増粘効果が弱く、高配合しなければ充分な安定性を付与することができないといった問題がある。また、高配合せざるを得ないことから、べたつくなど、使用感に悪影響を及ぼすといった問題もある。 However, although these attempts can improve the stability to some extent, the nonionic polysaccharide thickener has a weakening effect on its own and gives sufficient stability unless it is blended at a high level. There is a problem that can not be. Moreover, since it has to be highly compounded, there is also a problem that the feeling of use is adversely affected such as stickiness.
本発明は、前記従来技術に鑑みてなされたものであり、電解質を配合した乳化組成物において、保存安定性に優れるとともに、塗布時の使用感にも優れた皮膚用乳化組成物を提供することを課題とする。 The present invention has been made in view of the above prior art, and provides an emulsion composition for skin that is excellent in storage stability and excellent in use feeling during application in an emulsion composition containing an electrolyte. Is an issue.
即ち、本発明は、
〔1〕(A)電解質、(B)非イオン性界面活性剤、(C)ローカストビーンガム、並びに、(D)デンプンおよび/又はその誘導体を含有してなり、(C)成分と(D)成分の夫々の含有量が、質量含有比で、(C):(D)=1:1〜1:60を満たす皮膚用乳化組成物、
〔2〕(D)成分のデンプン誘導体が、アルケニルコハク酸デンプンの金属塩である前記〔1〕に記載の皮膚用乳化組成物、並びに
〔3〕(A)成分の含有量は、0.01〜15質量%であり、(B)成分の含有量は、0.01〜15質量%であり、(C)成分の含有量は、0.001〜5質量%であり、(D)成分の含有量は、0.05〜7質量%である前記〔1〕又は〔2〕に記載の皮膚用乳化組成物
に関する。
That is, the present invention
[1] (A) an electrolyte, (B) a nonionic surfactant, (C) locust bean gum, as well as, Ri Na contain (D) starch and / or derivatives thereof, (C) component and (D ) The emulsified composition for skin satisfying (C) :( D) = 1: 1 to 1:60, in which the content of each component is a mass content ratio ,
[2] The emulsion composition for skin according to [1] above, wherein the starch derivative of component (D) is a metal salt of alkenyl succinic acid starch, and the content of component (3) (A) is 0.01 The content of the component (B) is 0.01 to 15% by mass, the content of the component (C) is 0.001 to 5% by mass, and the component (D) Content is related with the emulsion composition for skin as described in said [1] or [2] which is 0.05-7 mass%.
本発明の皮膚用乳化組成物は、電解質による組成物の経時的な減粘を抑え、保存安定性に格段に優れた効果を奏する。また、塗布時のべたつき感がなく、延展性に優れムラ付きしないことから、延展時にダマやカスが生じ難く、優れた使用感を有するといった効果を奏する。 The emulsified composition for skin of the present invention suppresses the viscosity reduction of the composition over time due to the electrolyte, and has an excellent effect on storage stability. In addition, since there is no sticky feeling at the time of application, and the spreadability is excellent and there is no unevenness, there is an effect that it is difficult to cause lumps and debris at the time of spreading and has an excellent feeling of use.
本発明の皮膚用乳化組成物は、(A)電解質、(B)非イオン性界面活性剤、(C)ローカストビーンガムおよび/又はキサンタンガム、並びに、(D)デンプンおよび/又はその誘導体を含有する。 The emulsified composition for skin of the present invention contains (A) an electrolyte, (B) a nonionic surfactant, (C) locust bean gum and / or xanthan gum, and (D) starch and / or a derivative thereof. .
(A)成分の電解質は、通常、美白効果、保湿効果、消炎効果、収斂効果、紫外線吸収効果などを期待して配合されるものである。本発明においては、通常、化粧料原料として使用できるものであれば特に限定されず、目的に応じて適宜配合すればよい。 The electrolyte of the component (A) is usually blended with the expectation of a whitening effect, a moisturizing effect, a flame extinguishing effect, an astringent effect, an ultraviolet absorbing effect and the like. In the present invention, it is not particularly limited as long as it can be used as a cosmetic raw material, and may be appropriately blended depending on the purpose.
用いられる(A)成分のとしては、例えば、有機酸およびその塩、無機酸およびその塩が挙げられる。具体的には、例えば、無機カルシウム塩、無機カリウム塩、無機ナトリウム塩、無機マグネシウム塩などの無機塩;乳酸ナトリウム、乳酸マグネシウム、乳酸カルシウムなどの乳酸塩;コンドロイチン硫酸ナトリウム、ステアロイルコンドロイチン硫酸ナトリウムなどのコンドロイチン硫酸塩;デルマタン硫酸ナトリウムなどのデルマタン硫酸塩;リン酸カリウム、リン酸ナトリウム、ピロリン酸ナトリウムなどのリン酸塩;グリチルリチン酸ジカリウム塩などのグリチルリチン酸塩;アスコルビン酸リン酸エステルマグネシウム、アスコルビン酸リン酸エステルナトリウム、アスコルビン酸ナトリウム、L−アスコルビン酸硫酸エステル二ナトリウムなどのアスコルビン酸塩;ピロリドンカルボン酸ナトリウムなどのピロリドンカルボン酸塩;グリシン、トレオニン、アラニン、チロシン、バリン、ロイシン、アルギニン、プロリン、アスパラギン酸、グルタミン酸、セリンなどのアミノ酸およびこれらの誘導体;2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸およびそのナトリウム塩などの紫外線吸収剤などを例示することができる。これら(A)成分は、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いることもできる。 Examples of the component (A) used include organic acids and salts thereof, inorganic acids and salts thereof. Specifically, for example, inorganic salts such as inorganic calcium salts, inorganic potassium salts, inorganic sodium salts, and inorganic magnesium salts; lactates such as sodium lactate, magnesium lactate, and calcium lactate; sodium chondroitin sulfate, sodium stearoyl chondroitin sulfate, etc. Chondroitin sulfate; dermatan sulfate such as sodium dermatan sulfate; phosphates such as potassium phosphate, sodium phosphate and sodium pyrophosphate; glycyrrhizinate such as dipotassium glycyrrhizinate; magnesium ascorbate phosphate, phosphorus ascorbate Ascorbate such as sodium acid ester, sodium ascorbate, and disodium L-ascorbate sulfate; pyrrolidone carboxylic acid such as sodium pyrrolidonecarboxylate Amino acids such as glycine, threonine, alanine, tyrosine, valine, leucine, arginine, proline, aspartic acid, glutamic acid, serine and their derivatives; such as 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its sodium salt; An ultraviolet absorber etc. can be illustrated. These (A) components may be used individually by 1 type, and can also be used in combination of 2 or more type as appropriate.
(A)成分の含有量は、所望の効果が充分に付与されるのであれば特に限定されないが、通常、望む効果を付与する観点から、組成物中、0.01質量%以上が好ましく、より好ましくは0.05質量%以上である。また、保存安定性の観点から、15質量%以下が好ましく、より好ましくは10質量%以下である。これらの観点から、(A)成分の含有量は、好ましくは0.01〜15質量%、より好ましくは0.05〜10質量%である。 The content of the component (A) is not particularly limited as long as the desired effect is sufficiently imparted, but usually 0.01% by mass or more is preferable in the composition from the viewpoint of imparting the desired effect. Preferably it is 0.05 mass% or more. Moreover, from a viewpoint of storage stability, 15 mass% or less is preferable, More preferably, it is 10 mass% or less. From these viewpoints, the content of the component (A) is preferably 0.01 to 15% by mass, more preferably 0.05 to 10% by mass.
(B)成分の非イオン性界面活性剤としては、例えば、グリセリン脂肪酸エステル、グリセリン脂肪酸エステルの酸化エチレン縮合物、ポリアルキレングリコール脂肪酸エステル、ソルビタン脂肪酸エステル、ソルビタン脂肪酸エステルの酸化エチレン縮合物などの脂肪酸エステル型非イオン性界面活性剤の他、ポリオキシアルキレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンヒマシ油、ポリオキシエチレンラノリンなどが挙げられる。これら(B)成分は、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いることもできる。 Examples of the nonionic surfactant of the component (B) include fatty acids such as glycerin fatty acid ester, ethylene oxide condensate of glycerin fatty acid ester, polyalkylene glycol fatty acid ester, sorbitan fatty acid ester, and ethylene oxide condensate of sorbitan fatty acid ester. In addition to the ester type nonionic surfactant, polyoxyalkylene alkyl ether, polyoxyethylene hydrogenated castor oil, polyoxyethylene castor oil, polyoxyethylene lanolin and the like can be mentioned. These (B) components may be used individually by 1 type, and can also be used in combination of 2 or more types as appropriate.
グリセリン脂肪酸エステルとしては、本発明においては、グリセリン脂肪酸エステルおよびポリグリセリン脂肪酸エステルのいずれをも意味し、具体的には、モノカプリル酸グリセリル、モノカプリン酸グリセリル、モノラウリン酸グリセリル、モノミリスチン酸グリセリル、モノパルミチン酸グリセリル、モノステアリン酸グリセリル、モノイソステアリン酸グリセリル、モノベヘン酸グリセリル、モノオレイン酸グリセリル、モノエルカ酸グリセリル、セスキオレイン酸グリセリル、ジステアリン酸グリセリル、ジイソステアリン酸グリセリル、ジアラキン酸グリセリルなどのグリセリン脂肪酸エステル;モノカプリル酸ジグリセリル、モノカプリル酸デカグリセリル、モノカプリン酸ヘキサグリセリル、モノラウリン酸テトラグリセリル、モノラウリン酸ヘキサグリセリル、モノラウリン酸デカグリセリル、モノラウリン酸ポリ(4〜10)グリセリル、モノミリスチン酸デカグリセリル、モノステアリン酸デカグリセリル、モノイソステアリン酸デカグリセリル、モノステアリン酸ポリ(2〜10)グリセリル、モノオレイン酸ジグリセリル、モノオレイン酸ヘキサグリセリル、セスキオレイン酸ジグリセリル、ジイソステアリン酸ポリ(2〜10)グリセリル、ジステアリン酸ポリ(6〜10)グリセリル、トリイソステアリン酸ジグリセリル、トリステアリン酸ポリ(10)グリセリルなどの上記したグリセリン脂肪酸エステルの重合度2〜10のポリグリセリン脂肪酸エステルを例示することができる。また、グリセリン脂肪酸エステルの酸化エチレン縮合物としては、モノステアリン酸ポリオキシエチレングリセリル、モノオレイン酸ポリオキシエチレングリセリルなどを例示することができる。 The glycerin fatty acid ester, in the present invention, also means any glycerol fatty acid esters and polyglycerol fatty acid esters, specifically, glyceryl monocaprylate, monocaprate, glyceryl monolaurate, glyceryl monomyristate Glycerol fatty acids such as glyceryl, glyceryl monopalmitate, glyceryl monostearate, glyceryl monoisostearate, glyceryl monobehenate, glyceryl monooleate, glyceryl monoerucate, glyceryl sesquioleate, glyceryl distearate, glyceryl diisostearate, glyceryl diarachiate Esters: diglyceryl monocaprylate, decaglyceryl monocaprylate, hexaglyceryl monocaprate, tetraglyceryl monolaurate Hexaglyceryl monolaurate, decaglyceryl monolaurate, poly (4-10) glyceryl monolaurate, decaglyceryl monomyristate, decaglyceryl monostearate, decaglyceryl monoisostearate, poly (2-10) glyceryl monostearate, Diglyceryl monooleate, hexaglyceryl monooleate, diglyceryl sesquioleate, poly (2-10) glyceryl diisostearate, poly (6-10) glyceryl distearate, diglyceryl triisostearate, poly (10) tristearate ) Polyglycerol fatty acid esters having a polymerization degree of 2 to 10 of the above-described glycerol fatty acid esters such as glyceryl can be exemplified. Examples of the ethylene oxide condensate of glycerol fatty acid ester include polyoxyethylene glyceryl monostearate and polyoxyethylene glyceryl monooleate.
ポリアルキレングリコール脂肪酸エステルとしては、例えば、モノオレイン酸ポリエチレングリコール、モノステアリン酸ポリエチレングリコール、モノラウリン酸ポリエチレングリコールなどのポリエチレングリコール脂肪酸エステル;モノステアリン酸プロピレングリコール、モノラウリン酸プロピレングリコール、モノオレイン酸プロピレングリコールなどのプロピレングリコール脂肪酸エステルなどを例示することができる。 Examples of the polyalkylene glycol fatty acid ester include polyethylene glycol fatty acid esters such as polyethylene glycol monooleate, polyethylene glycol monostearate, polyethylene glycol monolaurate; propylene glycol monostearate, propylene glycol monolaurate, propylene glycol monooleate, etc. And propylene glycol fatty acid esters.
ソルビタン脂肪酸エステルとしては、例えば、モノオレイン酸ソルビタン、モノステアリン酸ソルビタン、モノイソステアリン酸ソルビタン、モノパルミチン酸ソルビタン、モノラウリン酸ソルビタン、トリオレイン酸ソルビタン、トリステアリン酸ソルビタン、セスキステアリン酸ソルビタン、セスキオレイン酸ソルビタン、セスキイソステアリン酸ソルビタン、ヤシ油脂肪酸ソルビタンなどのソルビタン脂肪酸エステルを例示することができる。また、ソルビタン脂肪酸エステルの酸化エチレン縮合物としては、モノラウリン酸ポリオキシエチレンソルビタン、モノパルミチン酸ポリオキシエチレンソルビタン、モノステアリン酸ポリオキシエチレンソルビタン、モノオレイン酸ポリオキシエチレンソルビタン、モノイソステアリン酸ポリオキシエチレンソルビタン、モノヤシ油脂肪酸ポリオキシエチレンソルビタン、トリステアリン酸ポリオキシエチレンソルビタン、トリオレイン酸ポリオキシエチレンソルビタンなどを例示することができる。 Examples of sorbitan fatty acid esters include sorbitan monooleate, sorbitan monostearate, sorbitan monoisostearate, sorbitan monopalmitate, sorbitan monolaurate, sorbitan trioleate, sorbitan tristearate, sorbitan sesquistearate, sesquioleate Examples include sorbitan fatty acid esters such as sorbitan, sorbitan sesquiisostearate, and coconut oil fatty acid sorbitan. Examples of the ethylene oxide condensate of sorbitan fatty acid ester include polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbitan monopalmitate, polyoxyethylene sorbitan monostearate, polyoxyethylene sorbitan monooleate, polyoxyethylene monoisostearate Examples include sorbitan, mono coconut oil fatty acid polyoxyethylene sorbitan, polyoxyethylene sorbitan tristearate, polyoxyethylene sorbitan trioleate, and the like.
ポリオキシアルキレンアルキルエーテルの具体例としては、例えば、ポリオキシエチレンラウリルエーテル、ポリオキシエチレンセチルエーテル、ポリオキシエチレンステアリルエーテル、ポリオキシエチレンオレイルエーテル、ポリオキシエチレンポリオキシプロピレンラウリルエーテル、ポリオキシプロピレンセチルエーテル、ポリオキシプロピレンイソセチルエーテル、ポリオキシプロピレンステアリルエーテル、ポリオキシプロピレンオレイルエーテルなどを例示することができる。 Specific examples of the polyoxyalkylene alkyl ether include, for example, polyoxyethylene lauryl ether, polyoxyethylene cetyl ether, polyoxyethylene stearyl ether, polyoxyethylene oleyl ether, polyoxyethylene polyoxypropylene lauryl ether, polyoxypropylene cetyl Examples include ether, polyoxypropylene isocetyl ether, polyoxypropylene stearyl ether, polyoxypropylene oleyl ether, and the like.
上記した(B)成分のうち、保存安定性の観点から、グリセリン脂肪酸エステル、グリセリン脂肪酸エステルの酸化エチレン縮合物、ポリアルキレングリコール脂肪酸エステル、ソルビタン脂肪酸エステル、ソルビタン脂肪酸エステルの酸化エチレン縮合物などの脂肪酸エステル型非イオン性界面活性剤を少なくとも1種用いるのが好ましい。 Among the components (B), fatty acids such as glycerin fatty acid ester, ethylene oxide condensate of glycerin fatty acid ester, polyalkylene glycol fatty acid ester, sorbitan fatty acid ester, ethylene oxide condensate of sorbitan fatty acid ester, from the viewpoint of storage stability. It is preferable to use at least one ester-type nonionic surfactant.
(B)成分の含有量は、所望の効果が充分に付与されるのであれば特に限定されないが、通常、保存安定性の観点から、組成物中、0.01質量%以上が好ましく、より好ましくは0.05質量%以上である。また、塗布時の使用感の観点から、15質量%以下が好ましく、より好ましくは10質量%以下である。これらの観点から、(B)成分の含有量は、好ましくは0.01〜15質量%、より好ましくは0.05〜10質量%である。 The content of the component (B) is not particularly limited as long as the desired effect is sufficiently imparted, but is usually preferably 0.01% by mass or more, more preferably in the composition from the viewpoint of storage stability. Is 0.05 mass% or more. Moreover, from a viewpoint of the usability at the time of application | coating, 15 mass% or less is preferable, More preferably, it is 10 mass% or less. From these viewpoints, the content of the component (B) is preferably 0.01 to 15% by mass, more preferably 0.05 to 10% by mass.
(C)成分のローカストビーンガムとは、ガラクトースとマンノースの繰り返し単位からなる鎖状多糖類である。また、キサンタンガムとは、グルコース2分子、マンノース2分子、グルクロン酸の繰り返し単位からなる鎖状多糖類である。本発明においては、ローカストビーンガムおよび/又はキサンタンガムを配合することで、電解質による化粧料の減粘を抑え、優れた保存安定性を付与することができる。 Component (C) locust bean gum is a chain polysaccharide composed of repeating units of galactose and mannose. Xanthan gum is a chain polysaccharide composed of repeating units of glucose 2 molecules, mannose 2 molecules, and glucuronic acid. In the present invention, by blending locust bean gum and / or xanthan gum, it is possible to suppress the thinning of the cosmetic due to the electrolyte and to impart excellent storage stability.
尚、(C)成分は、市販品をそのまま用いることもできる。ローカストビーンガムの市販品としては、例えば、イナゲル ローカストビーンガムCS(商品名,伊那食品工業社製)、メイプロ−LBG フレール M−175、メイプロ−LBG フレール M−200、メイプロ−LBG ラック(商品名,Danisco社製)、ゲニューガム RL−200−J(商品名,CP Kelco社製)などを例示することができる。また、キサンタンガムの市販品としては、例えば、エコーガムT(商品名,大日本住友製薬社製)、ノムコートZZ(商品名,日清オイリオグループ社製)などを例示することができる。 In addition, a commercial item can also be used for (C) component as it is. As a commercially available product of locust bean gum, for example, Inagel locust bean gum CS (trade name, manufactured by Ina Food Industry Co., Ltd.), Meipro-LBG Fler M-175, Meipro-LBG Fler M-200, Meipro-LBG Rack (trade name) , Danisco Co.), Genu gum RL-200-J (trade name, manufactured by CP Kelco), and the like. Examples of commercially available xanthan gum include Echo Gum T (trade name, manufactured by Dainippon Sumitomo Pharma Co., Ltd.), Nom Coat ZZ (trade name, manufactured by Nisshin Oillio Group, Inc.), and the like.
(C)成分の含有量は、所望の効果が充分に付与されるのであれば特に限定されないが、通常、保存安定性の観点から、組成物中、0.001質量%以上が好ましく、より好ましくは0.01質量%以上である。また、塗布時の使用感の観点から、5質量%以下が好ましく、より好ましくは3質量%以下である。これらの観点から、(C)成分の含有量は、好ましくは0.001〜5質量%、より好ましくは0.01〜3質量%である。 The content of the component (C) is not particularly limited as long as the desired effect is sufficiently imparted, but usually 0.001% by mass or more is preferable in the composition from the viewpoint of storage stability, and more preferable. Is 0.01% by mass or more. Moreover, from a viewpoint of the usability at the time of application | coating, 5 mass% or less is preferable, More preferably, it is 3 mass% or less. From these viewpoints, the content of the component (C) is preferably 0.001 to 5 mass%, more preferably 0.01 to 3 mass%.
(D)成分のデンプンとは、グルコース分子がグリコシド結合によって重合した鎖状多糖類であり、植物の根、茎、種子、果実から抽出されるものである。原料となる植物としては、ジャガイモ、小麦、トウモロコシ、サツマイモ、米、キャッサバ、クズ、カタクリ、緑豆、サゴヤシ、ワラビなどを例示することができるが、本発明においては、何れの植物由来であっても特に限定されない。 The starch (D) is a chain polysaccharide in which glucose molecules are polymerized by glycosidic bonds, and is extracted from plant roots, stems, seeds and fruits. Examples of the plant as a raw material include potato, wheat, corn, sweet potato, rice, cassava, kudzu, katakuri, mung bean, sago palm, bracken, etc., but in the present invention, any plant may be used. There is no particular limitation.
また、デンプン誘導体としては、例えば、グリセリルデンプン、ヒドロキシアルキルデンプン、ヒドロキシアルキルリン酸の金属塩、アルケニルコハク酸デンプンの金属塩などが挙げられる。金属塩としては、例えば、ナトリウム塩、マグネシウム塩、アルミニウム塩などの2価又は3価の金属塩を好適に用いることができる。 Examples of the starch derivative include glyceryl starch, hydroxyalkyl starch, metal salt of hydroxyalkyl phosphate, metal salt of alkenyl succinate starch, and the like. As the metal salt, for example, a divalent or trivalent metal salt such as a sodium salt, a magnesium salt, or an aluminum salt can be suitably used.
より具体的なデンプン誘導体としては、例えば、ヒドロキシプロピルデンプンなどのヒドロキシアルキルデンプン;ヒドロキシプロピルリン酸ナトリウムなどのヒドロキシアルキルリン酸の金属塩;オクテニルコハク酸デンプンナトリウム、オクテニルコハク酸デンプンアルミニウムなどのアルケニルコハク酸デンプンの金属塩などを例示することができる。 More specific starch derivatives include, for example, hydroxyalkyl starch such as hydroxypropyl starch; metal salt of hydroxyalkyl phosphate such as sodium hydroxypropyl phosphate; starch alkenyl succinate such as starch sodium octenyl succinate and starch aluminum octenyl succinate. Examples thereof include metal salts of
これら(D)成分は、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いることもできる。好適な(D)成分としては、電解質による化粧料の減粘を抑え、優れた保存安定性を付与する観点から、デンプン、アルケニルコハク酸デンプンの金属塩を用いることが好ましく、中でも、デンプン、オクテニルコハク酸デンプンアルミニウムを用いることがより好ましい。 These (D) components may be used alone or in a suitable combination of two or more. As a suitable component (D), it is preferable to use a metal salt of starch or alkenyl succinate, from the viewpoint of suppressing the viscosity reduction of the cosmetic due to the electrolyte and imparting excellent storage stability. Among them, starch, octenyl succinate are preferred. It is more preferable to use acid starch aluminum.
尚、(D)成分は、市販品をそのまま用いることもできる。デンプンの市販品としては、例えば、JPバレイショデンプン(商品名,日澱化学社製)、JPトウモロコシデンプン(商品名,日澱化学社製)などを例示することができる。また、オクテニルコハク酸デンプンアルミニウムの市販品としては、例えば、ドライフローPC(商品名,日本エヌエスシー社製)、オクティエ(商品名,日澱化学社製)などを例示することができる。 In addition, (D) component can also use a commercial item as it is. Examples of commercially available starch products include JP potato starch (trade name, manufactured by Nissho Chemical Co., Ltd.), JP corn starch (trade name, manufactured by Nissho Chemical Co., Ltd.), and the like. Examples of commercially available products of starch aluminum octenyl succinate include dry flow PC (trade name, manufactured by NSC Japan), octier (trade name, manufactured by Nippon Starch Chemical Co., Ltd.), and the like.
(D)成分の含有量は、所望の効果が充分に付与されるのであれば特に限定されないが、通常、保存安定性の観点から、組成物中、0.05質量%以上が好ましく、より好ましくは0.1質量%以上である。また、塗布時の使用感の観点から、7質量%以下が好ましく、より好ましくは5質量%以下である。これらの観点から、(D)成分の含有量は、好ましくは0.05〜7質量%、より好ましくは0.1〜5質量%である。 The content of the component (D) is not particularly limited as long as the desired effect is sufficiently imparted, but usually 0.05% by mass or more is preferable in the composition from the viewpoint of storage stability, and more preferable. Is 0.1% by mass or more. Moreover, from a viewpoint of the usability at the time of application | coating, 7 mass% or less is preferable, More preferably, it is 5 mass% or less. From these viewpoints, the content of the component (D) is preferably 0.05 to 7% by mass, more preferably 0.1 to 5% by mass.
本発明においては、電解質による化粧料の減粘を抑え、優れた保存安定性を付与するだけでなく、塗布時の延展性を良好にし、延展時のダマやカスの発生を抑え、べたつき感のない優れた使用感を有する皮膚用乳化組成物とすることができる観点から、上記した(C)成分と(D)成分の夫々の含有量が、下記質量含有比、
(C):(D)=1:1〜1:60
を満たす範囲内で調製されることが好ましい。
In the present invention, not only the viscosity reduction of the cosmetic due to the electrolyte is suppressed and excellent storage stability is imparted, but also the spreadability at the time of application is improved, the occurrence of lumps and debris at the time of spread is suppressed, and the sticky feeling From the viewpoint that the emulsified composition for skin having an excellent feeling of use can be obtained, the respective contents of the component (C) and the component (D) described above have the following mass content ratios,
(C) :( D) = 1: 1 to 1:60
It is preferable to be prepared within a range satisfying the above.
また、本発明の皮膚用乳化組成物には、塗布時の使用感を更に高める観点から、多価アルコールを含有させることができる。多価アルコールの具体例としては、例えば、エチレングリコール、ジエチレングリコール、トリエチレングリコール、ポリエチレングリコール、プロピレングリコール、ジプロピレングリコール、イソプレングリコール、1,3−ブチレングリコール、1,2−ブタンジオール、1,2−ペンタンジオール、1,2−ヘキサンジオール、1,2−オクタンジオール、1,2−デカンジオール、グリセリン、濃グリセリン、ジグリセリン、ポリグリセリンなどを例示することができる。これら成分は、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いることもできる。 Moreover, the emulsion composition for skin of this invention can be made to contain a polyhydric alcohol from a viewpoint which further improves the usability | use_condition at the time of application | coating. Specific examples of the polyhydric alcohol include, for example, ethylene glycol, diethylene glycol, triethylene glycol, polyethylene glycol, propylene glycol, dipropylene glycol, isoprene glycol, 1,3-butylene glycol, 1,2-butanediol, 1,2 -Pentanediol, 1,2-hexanediol, 1,2-octanediol, 1,2-decanediol, glycerin, concentrated glycerin, diglycerin, polyglycerin and the like can be exemplified. One of these components may be used alone, or two or more thereof may be used in appropriate combination.
多価アルコールの含有量は、所望の効果が充分に付与されるのであれば特に限定されないが、通常、使用感を高める観点から、組成物中、5質量%以上が好ましく、より好ましくは10質量%以上である。また、べたつきの観点から、40質量%以下が好ましく、より好ましくは25質量%以下である。これらの観点から、多価アルコールの含有量は、好ましくは5〜40質量%、より好ましくは10〜25質量%である。 The content of the polyhydric alcohol is not particularly limited as long as the desired effect is sufficiently imparted, but usually 5% by mass or more is preferable in the composition from the viewpoint of enhancing the feeling of use, and more preferably 10% by mass. % Or more. Moreover, from a sticky viewpoint, 40 mass% or less is preferable, More preferably, it is 25 mass% or less. From these viewpoints, the content of the polyhydric alcohol is preferably 5 to 40% by mass, more preferably 10 to 25% by mass.
本発明の皮膚用乳化組成物には、乳化系とするために油剤が配合される。用いられる油剤は特に限定されないが、例えば、高級アルコール、脂肪酸、油脂、炭化水素油、エステル油、シリコーン油などを例示することができる。これら油剤は、1種を単独で用いてもよく、2種以上を適宜組み合わせて用いることもできる。 In the emulsion composition for skin of the present invention, an oil agent is blended in order to obtain an emulsion system. Although the oil agent used is not specifically limited, For example, a higher alcohol, a fatty acid, fats and oils, hydrocarbon oil, ester oil, silicone oil etc. can be illustrated. These oil agents may be used alone or in combination of two or more.
具体的には、ラウリルアルコール、ミリスチルアルコール、セチルアルコール、ステアリルアルコール、オレイルアルコール、ラノリンアルコール、ベヘニルアルコール、セトステアリルアルコールなどの高級アルコール;ラウリン酸、ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、ベヘニン酸、ウンデシレン酸、ラノリン酸、イソステアリン酸などの脂肪酸;ヤシ油、パーム油、水素添加パーム油、アボカド油、ゴマ油、オリーブ油、ククイナッツ油、ブドウ粒子油、サフラワー油、アーモンド油、トウモロコシ油、綿実油、ヒマワリ種子油、ブドウ種子油、ヘーゼルナッツ油、マカデミアナッツ油、メドウフォーム油、ローズヒップ油などの油脂;オレフィンオリゴマー、軽質流動イソパラフィン、スクワラン、流動パラフィン、流動イソパラフィン、ワセリンなどの炭化水素油;オレイン酸エチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、ミリスチン酸ミリスチル、パルミチン酸セチル、オレイン酸オレイル、ミリスチン酸オクチルドデシル、オレイン酸オクチルドデシル、イソステアリン酸エチル、イソステアリン酸イソプロピル、2−エチルヘキサン酸セチル、2−エチルヘキサン酸セトステアリル、トリ2−エチルヘキサン酸グリセリル、トリ(カプリル・カプリン酸)グリセリル、トリイソパルミチン酸グリセリル、テトラ2−エチルヘキサン酸ペンタエリスリトール、オクタン酸イソセチル、オクタン酸イソステアリル、イソステアリン酸イソセチル、イソステアリン酸オクチルドデシル、ジメチルオクタン酸オクチルドデシルなどのエステル油;メチルポリシロキサン、高重合メチルポリシロキサン、メチルフェニルポリシロキサン、オクタメチルトリシロキサン、デカメチルテトラシロキサン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、メチルシクロポリシロキサン、アルコール変性シリコーン、アルキル変性シリコーン、アミノ変性シリコーン、エポキシ変性シリコーンなどのシリコーン油などを例示することができる。 Specifically, higher alcohols such as lauryl alcohol, myristyl alcohol, cetyl alcohol, stearyl alcohol, oleyl alcohol, lanolin alcohol, behenyl alcohol, cetostearyl alcohol; lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, behenic acid , Fatty acids such as undecylenic acid, lanolinic acid, isostearic acid; palm oil, palm oil, hydrogenated palm oil, avocado oil, sesame oil, olive oil, kukui nut oil, grape particle oil, safflower oil, almond oil, corn oil, cottonseed oil, Oils and fats such as sunflower seed oil, grape seed oil, hazelnut oil, macadamia nut oil, meadow foam oil, rosehip oil; olefin oligomer, light liquid isoparaffin, squalane, liquid paraffin Hydrocarbon oil such as ethyl oleate, isopropyl myristate, isopropyl palmitate, myristyl myristate, cetyl palmitate, oleyl oleate, octyldodecyl myristate, octyl dodecyl oleate, ethyl isostearate, Isopropyl isostearate, cetyl 2-ethylhexanoate, cetostearyl 2-ethylhexanoate, glyceryl tri-2-ethylhexanoate, glyceryl tri (capryl / caprate), glyceryl triisopalmitate, pentaerythritol tetra-2-ethylhexanoate , Isocetyl octoate, isostearyl octoate, isocetyl isostearate, octyldodecyl isostearate, octyldodecyl dimethyloctanoate, etc. Ester oil; methylpolysiloxane, highly polymerized methylpolysiloxane, methylphenylpolysiloxane, octamethyltrisiloxane, decamethyltetrasiloxane, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, methylcyclopolysiloxane And silicone oils such as alcohol-modified silicone, alkyl-modified silicone, amino-modified silicone, and epoxy-modified silicone.
油剤の含有量は、所望の効果が充分に付与されるのであれば特に限定されないが、通常、乳化の観点から、組成物中、0.1質量%以上が好ましく、より好ましくは1質量%以上である。また、塗布時の使用感の観点から、30質量%以下が好ましく、より好ましくは20質量%以下である。これらの観点から、油剤の含有量は、好ましくは0.1〜30質量%、より好ましくは1〜20質量%である。 The content of the oil agent is not particularly limited as long as the desired effect is sufficiently imparted, but usually from the viewpoint of emulsification, the content is preferably 0.1% by mass or more, more preferably 1% by mass or more. It is. Moreover, from a viewpoint of the usability at the time of application | coating, 30 mass% or less is preferable, More preferably, it is 20 mass% or less. From these viewpoints, the content of the oil is preferably 0.1 to 30% by mass, more preferably 1 to 20% by mass.
本発明の皮膚用乳化組成物には、本発明の効果を損なわない範囲内であれば、上記した成分の他に通常化粧品に用いられる成分、例えば、低級アルコール、金属封鎖剤、防腐剤、植物抽出エキス、香料、pH調整剤などを目的に応じて適宜配合することができる。 In the emulsified composition for skin of the present invention, within the range not impairing the effects of the present invention, in addition to the above-described components, components usually used in cosmetics, for example, lower alcohols, metal sequestering agents, preservatives, plants Extract extracts, fragrances, pH adjusters, and the like can be appropriately blended depending on the purpose.
尚、本発明の皮膚用乳化組成物は、前記各構成成分を混合し、公知の方法、例えばホモミキサーを用いた転相乳化法などにより乳化することにより製造することができる。また、混合と乳化は別々に行っても同時に行ってもよい。 In addition, the emulsion composition for skin of this invention can be manufactured by mixing each said component and emulsifying by a well-known method, for example, the phase inversion emulsification method using a homomixer. Moreover, mixing and emulsification may be performed separately or simultaneously.
以下、本発明を実施例に基づいて更に詳細に説明するが、本発明はこれら実施例にのみ限定されるものではない。尚、配合量は、特記しない限り「質量%」を表す。また、評価はすべて、23℃、湿度60%の恒温恒湿の一定条件下で実施した。 EXAMPLES Hereinafter, although this invention is demonstrated further in detail based on an Example, this invention is not limited only to these Examples. The blending amount represents “% by mass” unless otherwise specified. Moreover, all evaluation was implemented on the constant conditions of constant temperature and humidity of 23 degreeC and 60% of humidity.
(試料の調製1)
表1および表2に記した組成に従い、実施例1〜6および比較例1〜12の各皮膚用乳化組成物を常法に準じて調製し、下記評価に供した。なお、実施例2、3、及び5は、参考例とする。結果を表1〜表3に併記する。
(Sample preparation 1)
According to the composition described in Table 1 and Table 2, each skin emulsification composition of Examples 1-6 and Comparative Examples 1-12 was prepared according to the conventional method, and it used for the following evaluation. Examples 2, 3, and 5 are used as reference examples. The results are shown in Tables 1 to 3.
(試験例1:保存安定性の評価)
各実施例および各比較例で得られた皮膚用乳化組成物を、50mL容の透明ガラス容器にそれぞれ封入し、50℃の恒温槽に夫々3週間保存したときの乳化系の状態を目視観察して以下の評価基準に従って評価した。
(Test Example 1: Evaluation of storage stability)
The emulsified composition for skin obtained in each Example and each Comparative Example was enclosed in a 50 mL transparent glass container, and the state of the emulsified system was visually observed when stored in a 50 ° C. thermostat for 3 weeks. Evaluation was made according to the following evaluation criteria.
<保存安定性の評価基準>
◎:製造直後と全く変化が認められない
○:僅かな減粘が認められるものの、ほとんど変化は認められない
△:明らかな減粘が認められる
×:液状へと変化している、若しくは、分離している
<Evaluation criteria for storage stability>
◎: No change observed immediately after production ○: Slight decrease in viscosity is observed, but almost no change Δ: Clear decrease in viscosity is observed ×: Change to liquid or separated doing
(試験例2:塗布時の評価)
専門パネル20名により、各実施例および各比較例で得られた皮膚用乳化組成物を顔面へ塗布して使用試験を行い、塗布時の「べたつき感」、「延展性」および「使用感」に関し、以下の評価基準に従って官能評価した。
(Test Example 2: Evaluation during application)
20 specialist panels applied the emulsified skin composition obtained in each of the examples and comparative examples to the face to perform a use test, and “stickiness”, “extensibility” and “use feeling” at the time of application. Was subjected to sensory evaluation according to the following evaluation criteria.
<べたつき感の評価基準>
◎:20名中16名以上がべたつき感がないと回答
○:20名中11〜15名がべたつき感がないと回答
△:20名中6〜10名がべたつき感がないと回答
×:20名中5名以下がべたつき感がないと回答
<Evaluation criteria for stickiness>
A: Reply if 16 or more out of 20 people did not feel sticky ○: Reply if 11-15 people out of 20 did not feel sticky Δ: Reply if 6-10 out of 20 people did not feel sticky ×: 20 Less than 5 people answered that there was no stickiness
<延展性の評価基準>
◎:20名中16名以上がムラ付きなく延展性に優れると回答
○:20名中11〜15名がムラ付きなく延展性に優れると回答
△:20名中6〜10名がムラ付きなく延展性に優れると回答
×:20名中5名以下がムラ付きなく延展性に優れると回答
<Evaluation criteria for spreadability>
◎: Reply if 16 or more out of 20 people have no spread and excellent spreadability ○: Reply that 11 to 15 out of 20 people have excellent spreadability △: 6 to 10 out of 20 people have no unevenness Answer: Excellent spreadability x: 5 out of 20 respondents said that the spreadability is excellent without unevenness.
<使用感の評価基準>
◎:20名中16名以上が延展時にダマ又はカスが生じないと回答
○:20名中11〜15名が延展時にダマ又はカスが生じないと回答
△:20名中6〜10名が延展時にダマ又はカスが生じないと回答
×:20名中5名以下が延展時にダマ又はカスが生じないと回答
<Evaluation criteria for usability>
◎: More than 16 out of 20 responded that no lumps or dregs occurred during the extension ○: 11-15 out of 20 responded that no lumps or dregs occurred during the extension △: 6-10 out of 20 responded Answer that no lumps or scum sometimes occur ×: Less than 5 out of 20 replies that stagnation or scum does not occur at the time of extension
表1〜表3に示された結果から、各実施例で得られた皮膚用乳化組成物は、各比較例で得られた皮膚用乳化組成物と対比して、電解質である(A)成分が配合されているにもかかわらず、保存安定性に優れた効果を奏していることが分かる。また、塗布時のべたつき感がなく、延展性に優れ、ムラ付きしないことから、延展時にダマやカスが生じていないことが分かる。 From the results shown in Tables 1 to 3, the emulsified composition for skin obtained in each Example is an electrolyte as compared with the emulsified composition for skin obtained in each Comparative Example (A) component It can be seen that, despite the fact that is blended, it has an excellent effect on storage stability. Moreover, since there is no stickiness at the time of application | coating, it is excellent in spreadability and it does not become nonuniform, it turns out that neither the litter nor the residue is produced at the time of spread.
一方、本発明の(C)成分と(D)成分を併用しない、若しくは、他の増粘剤へ置き換えた各比較例の皮膚用乳化組成物では、保存安定性に劣るだけでなく、塗布時の使用感にも劣っていることが分かる。 On the other hand, the emulsified composition for skin of each comparative example in which the components (C) and (D) of the present invention are not used together or replaced with other thickeners is not only inferior in storage stability but also at the time of application. It turns out that the feeling of use is also inferior.
以下、本発明に係る皮膚用乳化組成物の処方例を示す。尚、含有量は質量%である。 Hereinafter, the formulation example of the emulsion composition for skin which concerns on this invention is shown. In addition, content is mass%.
(処方例1)
デンプン 1.0
オクテニルコハク酸デンプンアルミニウム 1.0
キサンタンガム 0.1
1,3−ブチレングリコール 5.0
グリセリン 5.0
ジプロピレングリコール 2.0
1,2−ペンタンジオール 0.5
塩化マグネシウム 0.5
乳酸 1.0
ピロリン酸ナトリウム 0.01
コンドロイチン硫酸ナトリウム 0.01
モノステアリン酸デカグリセリル 0.7
モノステアリン酸グリセリル 1.0
モノステアリン酸ポリオキシエチレンソルビタン(20E.O.) 2.0
流動パラフィン 5.0
エチルヘキサン酸セチル 3.0
ベヘニルアルコール 1.5
防腐剤 適 量
金属キレート剤 適 量
精製水 残 部
合 計 100.0
(Prescription Example 1)
Starch 1.0
Starch aluminum octenyl succinate 1.0
Xanthan gum 0.1
1,3-butylene glycol 5.0
Glycerin 5.0
Dipropylene glycol 2.0
1,2-pentanediol 0.5
Magnesium chloride 0.5
Lactic acid 1.0
Sodium pyrophosphate 0.01
Sodium chondroitin sulfate 0.01
Decaglyceryl monostearate0.7
Glyceryl monostearate 1.0
Polyoxyethylene sorbitan monostearate (20E.O.) 2.0
Liquid paraffin 5.0
Cetyl ethylhexanoate 3.0
Behenyl alcohol 1.5
Preservative appropriate amount Metal chelating agent appropriate amount
Purified water balance part Total 100.0
(処方例2)
デンプン 2.0
ローカストビーンガム 0.1
キサンタンガム 0.05
1,3−ブチレングリコール 7.0
グリセリン 10.0
オクタンジオール 0.1
1,2−ペンタンジオール 0.5
オクトキシグリセリン 0.2
乳酸マグネシウム 2.0
ピロリン酸ナトリウム 0.01
コンドロイチン硫酸ナトリウム 0.01
モノステアリン酸デカグリセリル 0.7
モノステアリン酸グリセリル 1.0
モノステアリン酸ポリオキシエチレンソルビタン(20E.O.) 2.0
スクワラン 5.0
メチルポリシロキサン 1.5
ベヘニルアルコール 1.0
防腐剤 適 量
金属キレート剤 適 量
精製水 残 部
合 計 100.0
(Prescription example 2)
Starch 2.0
Locust bean gum 0.1
Xanthan gum 0.05
1,3-butylene glycol 7.0
Glycerin 10.0
Octanediol 0.1
1,2-pentanediol 0.5
Octoxyglycerin 0.2
Magnesium lactate 2.0
Sodium pyrophosphate 0.01
Sodium chondroitin sulfate 0.01
Decaglyceryl monostearate0.7
Glyceryl monostearate 1.0
Polyoxyethylene sorbitan monostearate (20E.O.) 2.0
Squalane 5.0
Methylpolysiloxane 1.5
Behenyl alcohol 1.0
Preservative appropriate amount Metal chelating agent appropriate amount
Purified water balance part Total 100.0
(処方例3)
デンプン 2.0
ローカストビーンガム 0.1
キサンタンガム 0.05
1,3−ブチレングリコール 7.0
グリセリン 10.0
オクタンジオール 0.1
1,2−ペンタンジオール 0.5
オクトキシグリセリン 0.2
アスコルビン酸リン酸エステルナトリウム 3.0
モノステアリン酸デカグリセリル 0.7
モノステアリン酸グリセリル 1.0
モノステアリン酸ポリオキシエチレンソルビタン(20E.O.) 2.0
スクワラン 5.0
メチルポリシロキサン 1.5
ベヘニルアルコール 1.0
防腐剤 適 量
金属キレート剤 適 量
精製水 残 部
合 計 100.0
(Prescription Example 3)
Starch 2.0
Locust bean gum 0.1
Xanthan gum 0.05
1,3-butylene glycol 7.0
Glycerin 10.0
Octanediol 0.1
1,2-pentanediol 0.5
Octoxyglycerin 0.2
Sodium ascorbate phosphate 3.0
Decaglyceryl monostearate0.7
Glyceryl monostearate 1.0
Polyoxyethylene sorbitan monostearate (20E.O.) 2.0
Squalane 5.0
Methylpolysiloxane 1.5
Behenyl alcohol 1.0
Preservative appropriate amount Metal chelating agent appropriate amount
Purified water balance part Total 100.0
(処方例4)
デンプン 2.0
ローカストビーンガム 0.1
キサンタンガム 0.05
1,3−ブチレングリコール 7.0
グリセリン 10.0
オクタンジオール 0.1
1,2−ペンタンジオール 0.5
オクトキシグリセリン 0.2
アスコルビン酸リン酸エステルマグネシウム 3.0
モノステアリン酸デカグリセリル 0.7
モノステアリン酸グリセリル 1.0
モノステアリン酸ポリオキシエチレンソルビタン(20E.O.) 2.0
スクワラン 5.0
メチルポリシロキサン 1.5
ベヘニルアルコール 1.0
防腐剤 適 量
金属キレート剤 適 量
精製水 残 部
合 計 100.0
(Prescription Example 4)
Starch 2.0
Locust bean gum 0.1
Xanthan gum 0.05
1,3-butylene glycol 7.0
Glycerin 10.0
Octanediol 0.1
1,2-pentanediol 0.5
Octoxyglycerin 0.2
Ascorbic acid phosphate magnesium 3.0
Decaglyceryl monostearate0.7
Glyceryl monostearate 1.0
Polyoxyethylene sorbitan monostearate (20E.O.) 2.0
Squalane 5.0
Methylpolysiloxane 1.5
Behenyl alcohol 1.0
Preservative appropriate amount Metal chelating agent appropriate amount
Purified water balance part Total 100.0
Claims (3)
(C)成分と(D)成分の夫々の含有量が、質量含有比で、(C):(D)=1:1〜1:60を満たす皮膚用乳化組成物。 (A) an electrolyte, (B) a nonionic surfactant, (C) locust bean gum, and (D) starch and / or a derivative thereof,
The emulsified composition for skin which each content of (C) component and (D) component satisfy | fills (C) :( D) = 1: 1 to 1:60 by mass content ratio .
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010069404A JP5723104B2 (en) | 2010-03-25 | 2010-03-25 | Emulsion composition for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010069404A JP5723104B2 (en) | 2010-03-25 | 2010-03-25 | Emulsion composition for skin |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011201799A JP2011201799A (en) | 2011-10-13 |
JP5723104B2 true JP5723104B2 (en) | 2015-05-27 |
Family
ID=44878866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010069404A Active JP5723104B2 (en) | 2010-03-25 | 2010-03-25 | Emulsion composition for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5723104B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180023827A (en) * | 2016-08-25 | 2018-03-07 | 문득곤 | Cosmetic composition and method supplying the useful components in skin |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6674878B2 (en) * | 2016-09-29 | 2020-04-01 | 株式会社マンダム | Emulsified cosmetic |
JP6747763B2 (en) * | 2016-09-29 | 2020-08-26 | 株式会社マンダム | Emulsified cosmetics |
JP2018123067A (en) * | 2017-01-30 | 2018-08-09 | 日本精化株式会社 | Oil-in-water cosmetics |
US20190380933A1 (en) * | 2017-02-03 | 2019-12-19 | Adeka Corporation | Method for improving storage stability of cosmetic |
US20230107458A1 (en) * | 2020-03-23 | 2023-04-06 | Roquette Freres | Emulsifying and texturing composition based on starches and gums, for cosmetics |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040228819A1 (en) * | 2003-05-16 | 2004-11-18 | The Procter & Gamble Company | Cosmetic system for application as a multi-step cosmetic product |
FR2883733B1 (en) * | 2005-03-30 | 2012-02-03 | Lyofal | LYOPHILIZED MAKE-UP PRODUCT, COMPOSITIONS AND METHOD OF MANUFACTURING THE SAME |
US20070098667A1 (en) * | 2005-10-27 | 2007-05-03 | Jim Taneri | Methods and compositions for epilation |
US20070098660A1 (en) * | 2005-10-27 | 2007-05-03 | Jim Taneri | Methods and compositions for epilation |
JP5027601B2 (en) * | 2007-09-13 | 2012-09-19 | 株式会社ファンケル | Oil-in-water emulsion composition containing ascorbyl 2-phosphate magnesium salt |
-
2010
- 2010-03-25 JP JP2010069404A patent/JP5723104B2/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20180023827A (en) * | 2016-08-25 | 2018-03-07 | 문득곤 | Cosmetic composition and method supplying the useful components in skin |
KR101954525B1 (en) | 2016-08-25 | 2019-03-06 | 문득곤 | Cosmetic composition and method supplying the useful components in skin |
Also Published As
Publication number | Publication date |
---|---|
JP2011201799A (en) | 2011-10-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5723104B2 (en) | Emulsion composition for skin | |
JP4726151B2 (en) | Skin preparation for external use | |
JP6860297B2 (en) | Oil-in-water emulsified external preparation composition | |
JP5419506B2 (en) | Two-layer cleansing cosmetic | |
JP6009262B2 (en) | Emulsifying cleansing cosmetic | |
JP2011178667A (en) | Emulsion composition for skin | |
JP6118546B2 (en) | Oil-in-water emulsion composition | |
JP6226843B2 (en) | Cloudy cosmetic | |
JP4160463B2 (en) | Skin preparation | |
KR20150014279A (en) | Cleansing composition in the form of transparent or translucent gel | |
JP5227471B2 (en) | Liquid skin external preparation composition | |
JP2007223938A (en) | Emulsified cleansing cosmetic composition | |
JP2010024204A (en) | Skin care preparation | |
JP2014101290A (en) | Hair dye composition | |
JP2013159605A (en) | Skin preparation composition for external use | |
JP5797507B2 (en) | Cosmetic composition | |
JP2014234380A (en) | Oil-in-water type emulsion cosmetic | |
JP5164179B2 (en) | Liquid cosmetic | |
JP5495632B2 (en) | Skin cosmetics | |
JP7395267B2 (en) | oil-in-water cream cosmetics | |
JP6279216B2 (en) | Creamy composition | |
JP2023089889A (en) | Emulsion composition for skin | |
JP5999903B2 (en) | Liquid cosmetics | |
JP2022096945A (en) | Oil-in-water type emulsion cosmetic | |
JP2022176908A (en) | Oil-in-water emulsion cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120920 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131021 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131029 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131217 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140826 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20141125 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20150105 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150324 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150327 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5723104 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |